Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Biogen - Wikipedia

    en.wikipedia.org/wiki/Biogen

    Biogen stock is a component of several stock indices such as the S&P 500, S&P 1500, and NASDAQ-100 and the company is listed on the NASDAQ stock exchange under the ticker symbol, BIIB. [11] In May 2006, the company announced it would acquire cancer specialist, Conforma Therapeutics for $250 million. [12]

  3. List of largest biomedical companies by market capitalization

    en.wikipedia.org/wiki/List_of_largest_biomedical...

    The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.

  4. List of largest biomedical companies by revenue - Wikipedia

    en.wikipedia.org/wiki/List_of_largest_biomedical...

    List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...

  5. Biogen to buy Reata for $6.5 billion to bulk up rare ... - AOL

    www.aol.com/news/biogen-buy-reata-6-5-112140242.html

    Biogen said it will pay Reata $172.50 per share in cash, which represents a 58.9% premium to the stock's last closing price. Including debt, the deal values Reata at roughly $7.3 billion.

  6. Is Biogen's Stock Reasonable by the Numbers? - AOL

    www.aol.com/news/2012-01-20-is-biogens-stock...

    Let's see what those numbers can tell us about how expensive or cheap Biogen Idec (NAS: BIIB) might be. The current price multiples First, we'll look at most investors' favorite metric: the P/E ratio.

  7. Biogen (BIIB) Stock Up This Year So Far on Aduhelm Approval - AOL

    www.aol.com/news/biogen-biib-stock-far-aduhelm...

    Biogen's (BIIB) new Alzheimer's drug, Aduhelm should bring in huge revenues, if successfully commercialized.

  8. Boehringer Ingelheim - Wikipedia

    en.wikipedia.org/wiki/Boehringer_Ingelheim

    C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim, it operates ...

  9. Biogen to bulk up rare disease treatments with $7 ... - AOL

    www.aol.com/news/biogen-bulk-rare-disease...

    Biogen is spending more than $7 billion to buy Reata Pharmaceuticals and bolster its rare disease treatments. The Alzheimer’s treatment developer said Friday it will pay $172.50 in cash for each ...